Pharmaceutical Company
Outcome
Pharmaceutical Company Agrees to Pay $3.5 Million to Resolve Allegations of Violating False Claims Act
Details
Pharmaceutical Company — DOJ Enforcement (2020)
DOJ took enforcement action against Pharmaceutical Company in 2020 involving false claims act, anti kickback violations in the Hospitals / Health Systems sector.
Penalty: $3.5 million
Violation types: False Claims Act, Anti Kickback
Entity type: Hospital
Penalty type: Settlement
Source: DOJ Press Release — Pharmaceutical Company Agrees to Pay $3.5 Million to Resolve Allegations of Violating False Claims Act
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works